Market revenue in 2022 | USD 8,446.5 million |
Market revenue in 2030 | USD 17,217.2 million |
Growth rate | 9.3% (CAGR from 2022 to 2030) |
Largest segment | Diagnostics tests |
Fastest growing segment | Diagnostics Tests |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics Tests |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal biotechnology market will help companies and investors design strategic landscapes.
Diagnostics tests was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the North America animal biotechnology market based on diagnostics tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America animal biotechnology market, including forecasts for subscribers. This continent databook contains high-level insights into North America animal biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account